4-methylbenzene-1,2-diamine,sulfuric acid | CAS:1084893-43-5

We serve 4-methylbenzene-1,2-diamine,sulfuric acid CAS:1084893-43-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-methylbenzene-1,2-diamine,sulfuric acid

Chemical Name:4-methylbenzene-1,2-diamine,sulfuric acid
CAS.NO:1084893-43-5
Synonyms:3,4-Diaminotoluene sulfate; 4-Methylbenzene-1,2-diamine sulfate;
Molecular Formula:C7H12N2O4S
Molecular Weight:220.24600
 
Specification:
Appearance:White powder
Purity(HPLC):≥99.0%
Ash:≤0.5%
Moisture:≤0.5%
Fe content:≤100ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate
 



Contact us for information like 4-methylbenzene-1,2-diamine,sulfuric acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Methylbenzene-1,2-diamine sulfate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-methylbenzene-1,2-diamine,sulfuric acid Use and application,3,4-Diaminotoluene sulfate technical grade,usp/ep/jp grade.


Related News: South Korea said on Sunday that it would deny entry to any foreigners who have traveled to Wuhan and surrounding Hubei Province in China in the past 14 days.3-(Hydroxymethyl)phenylboronic acid manufacturer It has also sought to win acceptance for TCM overseas, establishing 30 overseas TCM centers in countries along the “Belt and Road Initiative,” Xi’s global infrastructure and investment program.(1R-cis)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane carboxylic acid supplier This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?1-CHLORO-4-PHENYLPHTHALAZINE vendor The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.